US Stock MarketDetailed Quotes
LEGN Legend Biotech
- 42.070
- -1.060-2.46%
Close Nov 29 13:00 ET
- 41.410
- -0.660-1.57%
Pre 04:51 ET
7.75BMarket Cap-21911P/E (TTM)
43.530High42.070Low460.23KVolume43.100Open43.130Pre Close19.55MTurnover0.56%Turnover RatioLossP/E (Static)184.29MShares70.13052wk High6.95P/B3.44BFloat Cap36.92052wk Low--Dividend TTM81.77MShs Float77.320Historical High--Div YieldTTM3.39%Amplitude23.410Historical Low42.487Avg Price1Lot Size
Legend Biotech Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 66.86%160.21M | 154.36%186.52M | 158.67%93.99M | 143.70%285.14M | 187.57%79.46M | 250.91%96.01M | 512.56%73.33M | -27.39%36.34M | 70.00%117.01M | 53.27%27.63M |
| Operating revenue | 66.60%159.92M | 151.27%184.1M | 149.90%90.66M | 144.23%284.96M | 189.43%79.42M | 251.64%95.99M | 513.78%73.27M | -27.44%36.28M | 78.40%116.68M | 55.93%27.44M |
| Cost of revenue | 27.58%55.47M | 54.42%50.45M | 53.71%54.74M | 120.64%144.21M | 41.31%32.45M | 70.77%43.48M | 92.88%32.67M | 35.61M | 65.36M | 22.96M |
| Gross profit | 99.37%104.74M | 234.67%136.07M | 5,329.05%39.25M | 172.90%140.93M | 906.94%47.01M | 2,663.49%52.53M | 918.40%40.66M | -98.56%723K | -24.97%51.64M | 4.67M |
| Operating expense | 20.64%174.79M | 23.07%177.62M | 25.87%156.5M | 14.42%580.41M | 26.52%166.86M | -1.09%144.88M | 26.26%144.33M | 7.65%124.34M | 10.01%507.26M | -15.57%131.89M |
| Selling and administrative expenses | 61.72%79.57M | 33.01%65.42M | 39.82%56.15M | 15.44%200.93M | 18.82%62.38M | 16.88%49.2M | 8.12%49.18M | 18.26%40.16M | 16.42%174.05M | -24.97%52.5M |
| -Selling and marketing expense | 109.83%44.27M | 40.29%30.06M | 34.92%24.22M | 0.79%94.16M | 30.41%33.68M | 11.91%21.1M | -21.91%21.43M | -15.72%17.95M | -8.90%93.42M | -51.10%25.82M |
| -General and administrative expense | 25.60%35.3M | 27.38%35.35M | 43.79%31.93M | 32.42%106.77M | 7.59%28.71M | 20.91%28.1M | 53.76%27.75M | 75.44%22.21M | 71.70%80.63M | 55.45%26.68M |
| Research and development costs | -0.35%95.52M | 17.57%112.63M | 18.94%100.96M | 13.87%382.22M | 30.87%105.68M | -8.29%95.86M | 39.18%95.79M | 4.10%84.89M | 7.12%335.65M | -6.64%80.76M |
| Other operating expenses | -73.86%-306K | 34.58%-420K | 13.24%-616K | -12.20%-2.73M | 12.06%-1.2M | -30.37%-176K | ---642K | ---710K | -40.21%-2.43M | -430.23%-1.37M |
| Operating profit | 24.14%-70.05M | 59.92%-41.55M | 5.15%-117.25M | 3.54%-439.49M | 5.80%-119.85M | 36.13%-92.35M | 13.09%-103.67M | -88.82%-123.62M | -16.14%-455.62M | 7.94%-127.22M |
| Net non-operating interest income expense | -12.69%11.13M | 69.45%11.57M | 411.27%8.4M | 1,350.69%32.69M | 40,907.14%11.48M | 831.99%12.74M | 515.40%6.83M | 257.28%1.64M | -3,781.69%-2.61M | 115.64%28K |
| Non-operating interest income | -9.71%16.63M | 41.96%17.05M | 105.33%13.87M | 565.94%54.49M | 253.90%17.3M | 1,122.30%18.42M | --12.01M | --6.76M | 742.64%8.18M | 1,055.79%4.89M |
| Non-operating interest expense | -3.03%5.5M | 5.77%5.48M | 7.08%5.48M | 101.87%21.79M | 19.73%5.82M | 74.75%5.68M | 215.58%5.19M | 389.75%5.11M | 1,099.56%10.8M | 707.48%4.86M |
| Other net income (expense) | -462.19%-61.96M | 111.78%12.02M | 390.65%49.07M | -1,005.88%-113.33M | -350.80%-38.44M | -72.19%17.11M | -41.37%-101.99M | -70.92%10M | 183.51%12.51M | -129.36%-8.53M |
| Gain on sale of security | ---- | 110.79%11.4M | 139.10%49.51M | -495.70%-85.09M | -18.03%-10.27M | -83.38%10.17M | -60.39%-105.7M | -40.67%20.71M | 446.82%21.5M | -127.91%-8.7M |
| Other non- operating income (expenses) | -115.25%-1.06M | -83.42%615K | 95.89%-440K | -214.01%-28.24M | -16,773.96%-28.18M | 2,115.97%6.94M | 159.41%3.71M | -1,978.64%-10.71M | -2.43%-8.99M | 108.00%169K |
| Income before tax | -93.43%-120.89M | 90.96%-17.97M | 46.60%-59.79M | -16.69%-520.12M | -8.17%-146.81M | 26.31%-62.5M | -2.99%-198.84M | -248.54%-111.97M | -9.46%-445.72M | -24.15%-135.72M |
| Income tax | 1,639.93%4.44M | -22.07%226K | -96.09%5K | -398.24%-1.86M | -1,403.27%-1.99M | -289.47%-288K | 84.71%290K | -21.47%128K | 117.29%625K | 104.23%153K |
| Net income | -101.46%-125.32M | 90.86%-18.2M | 46.66%-59.79M | -16.11%-518.25M | -6.58%-144.82M | 26.78%-62.21M | -3.05%-199.13M | -247.18%-112.1M | -10.60%-446.35M | -28.54%-135.88M |
| Net income continuous Operations | -101.46%-125.32M | 90.86%-18.2M | 46.66%-59.79M | -16.11%-518.25M | -6.58%-144.82M | 26.78%-62.21M | -3.05%-199.13M | -247.18%-112.1M | -10.60%-446.35M | -28.54%-135.88M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -101.46%-125.32M | 90.86%-18.2M | 46.66%-59.79M | -16.11%-518.25M | -6.58%-144.82M | 26.78%-62.21M | -3.05%-199.13M | -247.18%-112.1M | -10.60%-446.35M | -28.54%-135.88M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -101.46%-125.32M | 90.86%-18.2M | 46.66%-59.79M | -16.11%-518.25M | -6.58%-144.82M | 26.78%-62.21M | -3.05%-199.13M | -247.18%-112.1M | -10.60%-446.35M | -28.54%-135.88M |
| Basic earnings per share | -118.75%-0.7 | 91.23%-0.1 | 52.94%-0.32 | -5.00%-2.94 | 2.44%-0.8 | 38.46%-0.32 | 8.06%-1.14 | -240.00%-0.68 | 2.10%-2.8 | -36.67%-0.82 |
| Diluted earnings per share | -118.75%-0.7 | 91.23%-0.1 | 52.94%-0.32 | -5.00%-2.94 | 2.44%-0.8 | 38.46%-0.32 | 8.06%-1.14 | -240.00%-0.68 | 2.10%-2.8 | -36.67%-0.82 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
